Form 4: Fulgent Genetics COO Sells Shares, Gifts to Foundation

Fulgent Genetics' President and COO, Jian Xie, reported the sale of 10,000 shares for tax planning and gifted another 10,000 shares to a family foundation.

Summary

• Jian Xie, President and COO of Fulgent Genetics, Inc. (FLGT), reported transactions involving the company's common stock.
• On November 19, 2025, Mr. Xie sold 10,000 shares of common stock at a weighted-average price of $29.0983 per share.
• The sale was conducted for year-end tax planning purposes.
• On the same date, Mr. Xie transferred 10,000 shares of common stock as a gift to the James and Karena Xie Family Foundation.
• Following these transactions, Mr. Xie directly beneficially owns 339,768 shares of common stock.
• Additionally, 220,816 shares are indirectly beneficially owned by The Hsieh Family Dynasty Trust, where Mr. Xie serves on the investment committee.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (sale for tax planning, gift for philanthropy) which are generally neutral. While insider selling can sometimes be viewed negatively, the stated reason of 'year-end tax planning' suggests a personal financial decision rather than a reflection on company performance.

Positives

• The gift of 10,000 shares to the James and Karena Xie Family Foundation demonstrates philanthropic activity by the executive.

Negatives

• The sale of 10,000 shares by a key executive, even for tax planning, reduces direct insider ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The shares were sold by the reporting person for year-end tax planning.
• The reported price reflects the weighted-average sale price, with shares sold in multiple transactions ranging from $29.07 to $29.1985.
• The gift reflects shares transferred to the James and Karena Xie Family Foundation, where the reporting person is president and has voting and investment power.

Industry Context

This insider transaction report is specific to Fulgent Genetics and its executive's personal stock holdings, and does not directly provide broader industry trends or competitive analysis.

Related Party Transactions

• Gift of shares to the James and Karena Xie Family Foundation, where the reporting person is president and has voting and investment power.
• Indirect beneficial ownership of shares by The Hsieh Family Dynasty Trust, where Mr. Xie serves on the investment committee.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could be perceived as a slight negative, though the stated reason is personal tax planning. The overall impact on the company's operations or strategic direction is minimal.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Keywords

Fulgent Genetics, FLGT, Jian Xie, Insider Transaction, Form 4, Share Sale, Stock Gift, Executive Ownership